Biomarkers in Cardiorenal Syndromes

被引：20
作者：
Fu, Shihui [1 ,2 ,3 ]
Zhao, Shaopan [1 ]
Ye, Ping [1 ]
Luo, Leiming [1 ]
机构：
[1] Chinese Peoples Liberat Army Gen Hosp, Dept Geriatr Cardiol, Beijing 100853, Peoples R China
[2] Chinese Peoples Liberat Army Gen Hosp, Dept Cardiol, Beijing 100853, Peoples R China
[3] Chinese Peoples Liberat Army Gen Hosp, Hainan Branch, Beijing 100853, Peoples R China
来源：
BIOMED RESEARCH INTERNATIONAL | 2018年 / 2018卷
关键词：
CHRONIC KIDNEY-DISEASE; C-REACTIVE PROTEIN; ACUTE MYOCARDIAL-INFARCTION; CHRONIC HEART-FAILURE; CARDIAC TROPONIN-T; BRAIN NATRIURETIC PEPTIDE; PROGNOSTIC VALUE; CARDIOVASCULAR RISK; INJURY MOLECULE-1; CYSTATIN C;
D O I：
10.1155/2018/9617363
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
There is a consensus that cardiorenal syndromes (CRS) are defined as the disorders of heart and kidney where acute or chronic dysfunction in one organ may induce acute or chronic dysfunction in another. Patients with CRS have increased hospitalization and mortality rates, and thus their identification is of great implication. Biomarkers are not only predictive in heart failure or renal diseases, but also useful in identifying cardiac dysfunction in renal diseases and renal injury in heart failure. Thus, they may be applied in order to identify patients with CRS and even assess prognosis and guide therapy in these patients. However, studies on biomarkers have just begun in CRS. Future studies are essential to observe current biomarkers and find novel biomarkers in CRS so as to improve diagnosis, therapy, and prognosis of CRS.
引用
收藏
页数：8
相关论文
共 74 条
  • [1] Biomarker-based risk prediction in the community
    AbouEzzeddine, Omar F.
    McKie, Paul M.
    Scott, Christopher G.
    Rodeheffer, Richard J.
    Chen, Horng H.
    Felker, G. Michael
    Jaffe, Allan S.
    Burnett, John C.
    Redfield, Margaret M.
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2016, 18 (11) : 1342 - 1350
  • [2] Myeloperoxidase Levels and Its Product 3-Chlorotyrosine Predict Chronic Kidney Disease Severity and Associated Coronary Artery Disease
    Afshinnia, Farsad
    Zeng, Lixia
    Byun, Jaeman
    Gadegbeku, Crystal A.
    Magnone, Maria Chiara
    Whatling, Carl
    Valastro, Barbara
    Kretzler, Matthias
    Pennathur, Subramaniam
    [J]. AMERICAN JOURNAL OF NEPHROLOGY, 2017, 46 (01) : 73 - 81
  • [3] The Urotensin II Systemand Carotid Atherosclerosis: A Role in Vascular Calcification
    Albanese, Isabella
    Daskalopoulou, Stella S.
    Yu, Bin
    You, Zhipeng
    Genest, Jacques
    Alsheikh-Ali, Alawi
    Schwertani, Adel G.
    [J]. FRONTIERS IN PHARMACOLOGY, 2016, 7
  • [4] Multi-marker strategies in heart failure: clinical and statistical approaches
    Allen, Larry A.
    Felker, G. Michael
    [J]. HEART FAILURE REVIEWS, 2010, 15 (04) : 343 - 349
  • [5] [Anonymous], VASCULAR HLTH RISK M
  • [6] [Anonymous], BIOMED RES INT
  • [7] [Anonymous], ARQUIVOS BRASILEIROS
  • [8] Prognostic value of different biomarkers for cardiovascular death in unselected older patients in the emergency department
    Bahrmann, Philipp
    Christ, Michael
    Hofner, Benjamin
    Bahrmann, Anke
    Achenbach, Stefan
    Sieber, Cornel Christian
    Bertsch, Thomas
    [J]. EUROPEAN HEART JOURNAL-ACUTE CARDIOVASCULAR CARE, 2016, 5 (08) : 568 - 578
  • [9] Analyzing the Release of Copeptin from the Heart in Acute Myocardial Infarction Using a Transcoronary Gradient Model
    Boeckel, Jes-Niels
    Oppermann, Jana
    Anadol, Remzi
    Fichtlscherer, Stephan
    Zeiher, Andreas M.
    Keller, Till
    [J]. SCIENTIFIC REPORTS, 2016, 6
  • [10] Copeptin (CTproAVP), a new tool for understanding the role of vasopressin in pathophysiology
    Bolignano, Davide
    Cabassi, Aderville
    Fiaccadori, Enrico
    Ghigo, Ezio
    Pasquali, Renato
    Peracino, Andrea
    Peri, Alessandro
    Plebani, Mario
    Santoro, Antonio
    Settanni, Fabio
    Zoccali, Carmine
    [J]. CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2014, 52 (10) : 1447 - 1456
12345678